What Jeff Bridges' Story Can Help Us Understand About Lymphoma

What Jeff Bridges made public

On October 19, 2020, the actor Jeff Bridges posted that he had been diagnosed with lymphoma. "Although it is a serious disease, I feel fortunate that I have a great team of doctors and the prognosis is good," he wrote. He said he was starting treatment.

Eleven months later he posted an update. His cancer was in remission. The mass, he wrote, had shrunk "down to the size of a marble." He also caught COVID-19 while chemotherapy had left his immune system weak. He spent five weeks in the hospital. "My dance with Covid makes my cancer look like a piece of cake," he wrote.

Bridges did not name a subtype, so this page will not guess at one. The rest of this article is about the disease.

One word, many diseases

Lymphoma begins in the lymph system. That is the network of vessels, small glands and organs that helps the body fight infection. It includes the tonsils, the thymus, the spleen, the bone marrow and hundreds of lymph nodes.

Doctors sort lymphoma into two large groups: Hodgkin lymphoma and non-Hodgkin lymphoma. Non-Hodgkin lymphoma is the bigger group. About 85 percent of cases start in B cells, a white blood cell that makes antibodies.

The National Cancer Institute then splits non-Hodgkin lymphoma again, by how fast it grows. Indolent lymphoma grows slowly and causes few symptoms. Aggressive lymphoma grows fast and can make a person quite sick. The two are treated in different ways. Our guide to lymphoma walks through the main subtypes.

What sends people to the doctor

The most common sign is a swollen lymph node in the neck, the armpit, the groin or the abdomen. It is usually painless. NCI also lists fever with no clear cause, drenching night sweats, weight loss with no clear cause, deep tiredness, itchy skin or a rash, and unexplained pain in the chest, abdomen or bones.

When fever, drenching night sweats and weight loss show up together, doctors call them B symptoms. That grouping is not a label for paperwork. It goes into the staging and helps shape the plan.

When to get checked

Book an appointment if any of these apply:

• A lump in the neck, armpit or groin that has lasted more than two weeks and is not shrinking.
• A lymph node that keeps growing, or is firm and does not move under the skin.
• Night sweats that soak your bedclothes or sheets, night after night.
• Losing more than 10 percent of your body weight in six months without trying.
• Fever with no infection to explain it, coming back over weeks.

Most swollen nodes are caused by ordinary infections and go away. The pattern that matters is a node that persists, grows or comes with those other symptoms.

Getting to a diagnosis

Scans alone cannot diagnose lymphoma. A doctor needs tissue. An excisional biopsy takes out a whole lymph node. A core biopsy takes a piece using a wide needle. In one review of more than 32,000 French cases, excisional biopsy gave a firm answer 98.1 percent of the time, and core needle biopsy 92.3 percent of the time.

The tissue then goes through several lab tests. Immunophenotyping identifies the cells by the markers on their surface. Cytogenetic analysis and FISH look for changes in the chromosomes. These tests are how the subtype is named, and the subtype drives everything after it.

Staging usually adds a CT scan, a PET scan and often a bone marrow biopsy. Blood work includes a complete blood count and a test called LDH. Doctors also check for hepatitis B, hepatitis C and HIV before treatment starts, because some drugs can wake up an old infection.

What treatment involves

Treatment depends on subtype, stage and how the person is doing overall. Slow-growing lymphoma is sometimes watched rather than treated at first, an approach called watchful waiting. Early-stage indolent lymphoma can respond to radiation alone.

Aggressive lymphoma is usually treated right away with combination chemotherapy, often with an antibody drug added. Bridges' own account points at a real risk of that path: chemotherapy lowers the white blood cells that fight infection, and an ordinary virus can then become dangerous.

The survival picture

For 2026 the American Cancer Society projects 79,320 new cases of non-Hodgkin lymphoma in the United States and 19,970 deaths, published by SEER, the federal cancer statistics program. SEER's own follow-up gives five-year relative survival across the whole group of 74.3 percent for people diagnosed from 2016 through 2022. About 2.0 percent of people are diagnosed at some point in life.

NCI adds detail by group. Indolent lymphoma has a median survival as long as 20 years, but it is usually not curable once it is advanced. Aggressive lymphoma looks worse early on, yet more than 70 percent of people with it can be cured.

Those are group numbers. They describe thousands of people diagnosed years ago, under older treatments. They do not forecast one person's course.

What this does not mean

Remission is not the end of medical care. NCI notes that survivors carry a raised risk of second cancers for as long as three decades, along with heart, bone and immune effects from some treatments. That is why follow-up schedules continue long after treatment stops, as our page on survivorship explains.

One person's remission also says nothing about anyone else's odds. Bridges had one subtype, one stage and one treatment plan, and he has shared almost none of that detail.

Sources

• https://variety.com/2020/film/news/jeff-bridges-lymphoma-1234810262/
• https://www.nbcnews.com/news/ncna1279072
• https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq
• https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq
• https://seer.cancer.gov/statfacts/html/nhl.html

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.